OptiNose EV 2011-2026 | OPTN

EV Jährlich OptiNose

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
312 M	264 M	169 M	230 M	309 M	140 M	68.6 M	8.59 M	43.2 M	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
312 M	8.59 M	172 M

EV anderer Aktien in der Arzneimittelhersteller

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
Aerie Pharmaceuticals AERI	737 M	-	-	$ 754 M	USA
AcelRx Pharmaceuticals ACRX	23.6 M	-	7.5 %	$ 6.35 M	USA
Catalent CTLT	16.7 B	-	-	$ 11.5 B	USA
Adamis Pharmaceuticals Corporation ADMP	28.5 M	-	0.86 %	$ 117 M	USA
DURECT Corporation DRRX	3.37 M	-	-	$ 50.1 M	USA
Canopy Growth Corporation CGC	459 M	$ 1.12	5.19 %	$ 120 M	Canada
Endo International plc ENDP	-710 M	-	-	$ 28.9 M	Irlanda
Agile Therapeutics AGRX	25.3 M	-	10.11 %	$ 58.2 M	USA
Evoke Pharma EVOK	7.15 M	-	-	$ 36.6 M	USA
Alimera Sciences ALIM	197 M	-	-	$ 142 M	USA
Cronos Group CRON	3.84 B	$ 2.67	2.5 %	$ 1.38 B	Canada
Evolus EOLS	467 M	$ 5.34	29.21 %	$ 344 M	USA
Avadel Pharmaceuticals plc AVDL	756 M	-	-	$ 2.06 B	France
Jupiter Wellness JUPW	91.9 M	-	-	$ 33.6 M	USA
China Pharma Holdings CPHI	11.1 M	$ 0.57	0.79 %	$ 9.95 M	China
Cumberland Pharmaceuticals CPIX	124 M	$ 4.44	-3.06 %	$ 62.4 M	USA
Calliditas Therapeutics AB (publ) CALT	10.2 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	284 M	-	2.45 %	$ 38.1 M	Canada
Neoleukin Therapeutics NLTX	-110 M	-	-	$ 193 M	Canada
Aurora Cannabis ACB	106 M	$ 3.7	6.32 %	$ 86.3 M	Canada
Harrow Health HROW	2.21 B	$ 40.3	4.39 %	$ 1.48 B	USA
Athenex ATNX	209 M	-	-23.39 %	$ 1.76 M	USA
Emergent BioSolutions EBS	1.2 B	$ 8.91	0.06 %	$ 456 M	USA
ProPhase Labs PRPH	145 M	-	-	$ 5.07 M	USA
Assertio Holdings ASRT	141 M	$ 12.18	2.4 %	$ 865 M	USA
Radius Health RDUS	700 M	-	-	$ 1.42 B	USA
Bausch Health Companies BHC	29.9 B	$ 5.62	-1.75 %	$ 2.05 B	Canada
Lannett Company LCI	648 M	-	1.15 %	$ 7.11 M	USA
Eagle Pharmaceuticals EGRX	457 M	-	-39.89 %	$ 27.7 M	USA
Organogenesis Holdings ORGO	392 M	$ 2.92	1.57 %	$ 384 M	USA
OrganiGram Holdings OGI	456 M	$ 1.4	2.17 %	$ 402 M	Canada
Rockwell Medical RMTI	57.3 M	$ 0.9	0.18 %	$ 21 M	USA
Perrigo Company plc PRGO	7.03 B	$ 11.74	3.12 %	$ 1.63 B	USA
Sundial Growers SNDL	-2.47 M	$ 1.56	1.63 %	$ 3.37 M	Canada
TherapeuticsMD TXMD	33.6 M	$ 2.26	1.77 %	$ 23.6 M	USA
Veru VERU	111 M	$ 2.66	5.56 %	$ 359 M	USA
Viatris VTRS	41.3 B	$ 14.89	-	$ 17.9 B	USA
Pacira BioSciences PCRX	1.68 B	$ 22.5	1.81 %	$ 1.04 B	USA
PetIQ PETQ	280 M	-	1.64 %	$ 400 M	USA
PLx Pharma PLXP	73.8 M	-	-27.8 %	$ 2.56 M	USA
Recro Pharma REPH	220 M	-	-4.76 %	$ 65.3 M	USA
Relmada Therapeutics RLMD	170 M	$ 4.83	3.43 %	$ 145 M	USA
cbdMD YCBD	7.85 M	$ 0.83	7.46 %	$ 3.58 M	USA
SCYNEXIS SCYX	91.7 M	$ 0.74	-1.56 %	$ 35.4 M	USA
Solid Biosciences SLDB	197 M	$ 6.09	2.18 %	$ 249 M	USA
Sonoma Pharmaceuticals SNOA	7.57 M	$ 2.77	0.65 %	$ 3.44 M	USA
Tricida TCDA	506 M	-	-	$ 3.25 M	USA
Tilray TLRY	1.96 B	$ 7.54	2.38 %	$ 4.66 B	Canada
Zynerba Pharmaceuticals ZYNE	-22.6 M	-	-	$ 55.5 M	USA